Showing
1 - 4
results of
4
for search '
Snedecor SJ
'
Skip to content
Home
Collections
High Impact Articles
Jawi Collection
Malay Medicine
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Snedecor SJ
Showing
1 - 4
results of
4
for search '
Snedecor SJ
'
, query time: 0.04s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Associations between signs and symptoms of dry eye disease: a systematic review
by
Bartlett JD
,
Keith MS
,
Sudharshan L
,
Snedecor
SJ
Published 2015-09-01
Get full text
Article
2
Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis...
by
Aletaha D
,
Snedecor
SJ
,
Ektare V
,
Xue M
,
Bao Y
,
Garg V
Published 2017-07-01
Get full text
Article
3
Cost-effectiveness of intravenous vedolizumab vs subcutaneous adalimumab for moderately to severely active ulcerative colitis
by
Carter, J.A
,
Diakite, I.
,
Schultz, B.G
,
Snedecor
,
S.J
,
Turpin, R.
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
4
Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury
by
Snedecor
SJ
,
Sudharshan L
,
Cappelleri JC
,
Sadosky A
,
Desai P
,
Jalundhwala YJ
,
Botteman M
Published 2013-07-01
Get full text
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
Adalimumab
Anti-Inflammatory Agents
Antibodies, Monoclonal, Humanized
Article
Cohort Studies
Colitis, Ulcerative
Cost-Benefit Analysis
Decision Trees
Gastrointestinal Agents
Humans
Insurance, Health
adalimumab
adult
antiinflammatory agent
clinical outcome
clinical trial
cohort analysis
cost benefit analysis
cost effectiveness analysis
cyclosporine
decision tree
disease severity
drug cost
drug efficacy
drug safety
economic model
economics
endoscopy
gastrointestinal agent
golimumab
Loading...